Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis: A Randomized Controlled Exploratory Study

NCT06951776 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06951776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06951776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis: A Randomized Controlled Exploratory Study
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
December 30, 2025
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

circadian rhythm disorders, osteoporosis